P2.17-10 Daily Low–Dose Cisplatin and High Dose Radiotherapy for Elderly Patients With Stage III NSCLC Is Well Tolerated.
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1536
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV